NCT00637195 2020-01-03
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
GlaxoSmithKline
Phase 3 Completed
GlaxoSmithKline
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba